Vinati Organics Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹13,712 Cr
- Book Value
- ₹311
- Stock P/E
- 27.5
- Dividend Yield
- 0.57%
- ROE
- 16.2%
- ROCE
- 21.3%
- PEG Ratio
- 2.18
- EV/EBITDA
- 18.1
Fundamentals from Screener.in, as of 5 Aug 2026. Live price via Yahoo Finance.
Technical snapshot
EOD ·Vinati Organics Ltd closed at ₹1,326.70 on 19 August 2026, down 0.9% on the day, 0.0% below its 50-day average, 28.3% below its 52-week high, with volume at 0.46× its 20-session average.
- RSI 14
- 50.2
- vs 50-day SMA
- -0.0%
- vs 200-day SMA
- -7.2%
- From 52-week high
- -28.3%
- Relative volume
- 0.46×
- 20-day return
- +1.0%
End-of-day prices from exchange-published files (NSE/BSE bhavcopy), updated after market close. Descriptive statistics, not investment advice.
Vinati Organics share price today
Vinati Organics (NSE: VINATIORGA) is what winning a molecule globally looks like: 65%+ world share in ATBS, a specialty monomer the oil-field, water-treatment and acrylics industries cannot substitute, built through two decades of process-engineering obsession that made Vinati the lowest-cost, highest-purity producer on earth. IBB (the ibuprofen precursor) and a widening portfolio (butyl phenols, antioxidants) apply the same playbook: pick a niche molecule, own its economics globally.
The current chapter is a trough — growth flat for three years as specialty-chemical destocking ground through the industry — with the franchise metrics intact beneath: 29.5% operating margins, zero debt, 21.3% ROCE. At 27.5×, the valuation assumes a recovery that has not yet appeared in reported growth.
The molecule-monopoly playbook
ATBS demand grows structurally (enhanced oil recovery, water treatment chemistries) and cyclically (customer inventory swings — the current drag). Vinati’s moat is manufacturing depth: backward integration into feedstocks, purity levels rivals miss, and scale that makes competing capacity uneconomic. The next molecules (antioxidants for polymers, MEHQ/ANISOLE chemistry) are seeded and scaling, each aiming at the same global-leadership template.
What matters next: ATBS volume recovery (the restock signal), new-molecule ramp rates, competitor capacity announcements (rare but decisive), and promoter execution consistency (74.3% held, zero pledge).
The numbers
Financial snapshot — 5 August 2026
| Metric | Value |
|---|---|
| Market cap | ₹13,712 Cr |
| P/E (TTM) | 27.5 |
| EV/EBITDA | 18.1 |
| Operating margin | 29.5% |
| ROE / ROCE | 16.2% / 21.3% |
| Debt to equity | 0.00 |
| Sales CAGR (5y) | 18.5% |
| Profit CAGR (5y) | 12.6% |
| Promoter holding | 74.3% |
| EPS (TTM) | ₹47.99 |
Vinati Organics share price target 2026 to 2030
EPS base ₹47.99 (TTM). Bear: the trough lingers, new molecules ramp slowly — 6% growth, multiple at 18×. Base: restocking returns ATBS to trend — 12% growth at 24×. Bull: new molecules replicate the ATBS win — 17% growth at 31×.
From ₹1,320, the base case is ≈ +54% over four and a half years plus a 0.6% yield; the bear is −12%. The range separates a durable molecule franchise from uncertainty over how long the current trough lasts.
What supports the case
- 65%+ global ATBS share — a genuine molecule monopoly, cost-defended.
- Zero debt and 29.5% margins straight through the industry’s worst destock.
- The new-molecule pipeline reruns a proven global-leadership playbook.
- Process-engineering depth is the moat capital can’t shortcut.
- Promoter discipline: 74.3% held, no pledge, no dilution habit.
The risks: the trough has outlasted most forecasts, single-molecule concentration cuts both ways, and new molecules must scale to justify the franchise multiple.
What to weigh at the current price
The tension is whether ATBS restocking and new molecules can restore growth before a longer trough or new capacity weakens the economics behind Vinati’s global share.
FAQ
What is the Vinati Organics share price target for 2030? The table above sets out bear, base and bull scenarios for each year to 2030. They are valuation sensitivities, not promised prices.
What is ATBS used for? A specialty monomer in polymers for enhanced oil recovery, water treatment, acrylic fibres and adhesives — performance chemistry with few substitutes at scale.
Why has growth been flat for three years? Global specialty-chemical customers destocked after the supply-chain panic, cutting orders below consumption. The franchise’s margins held — the volumes are the cycle’s to return.
When are Vinati Organics’ next results? Check the results calendar and confirm the announced date in the relevant exchange filing.
This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.